prikaz prve stranice dokumenta Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
  Preuzmi
PDF 711.08 KB
Znanstveni rad - Izvorni znanstveni rad
Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
Vaccines, 9 (2021), 2; 104. https://doi.org/10.3390/vaccines9020104
Gorun, Florin; Malita, Daniel; Ciohat, Ioana; Vilibi-Čavlek, Tatjana; Feier, Horea; Tabain, Irena; Craina, Marius; Cretu, Octavian; Navolan, Dan

Citirajte ovaj rad

Gorun, F., Malita, D., Ciohat, I., Vilibi Čavlek, T., Feier, H., Tabain, I. ... Navolan, D. (2021). Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization. Vaccines, 9. (2). doi: 10.3390/vaccines9020104

Gorun, Florin, et al. "Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization." Vaccines, vol. 9, br. 2, 2021. https://doi.org/10.3390/vaccines9020104

Gorun, Florin, Daniel Malita, Ioana Ciohat, Tatjana Vilibi Čavlek, Horea Feier, Irena Tabain, Marius Craina, Octavian Cretu i Dan Navolan. "Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization." Vaccines 9, br. 2 (2021). https://doi.org/10.3390/vaccines9020104

Gorun, F., et al. (2021) 'Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization', Vaccines, 9(2). doi: 10.3390/vaccines9020104

Gorun F, Malita D, Ciohat I, Vilibi Čavlek T, Feier H, Tabain I, i sur.. Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization. Vaccines [Internet]. 29.01.2021. [pristupljeno 10.04.2024.];9(2). doi: 10.3390/vaccines9020104

F. Gorun, et al., "Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization", Vaccines, vol. 9, br. 2, Siječanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:126512. [Citirano: 10.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:126512
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Prevalence of Rubella Antibodies among Fertile Women in the West of Romania, 18 Years after the Implementation of Immunization
AutorFlorin Gorun
AutorDaniel Malita
AutorIoana Ciohat
AutorTatjana Vilibi-Čavlek
AutorHorea Feier
AutorIrena Tabain
AutorMarius Craina
AutorOctavian Cretu
AutorDan Navolan
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA MEDICINSKU MIKROBIOLOGIJU I PARAZITOLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Medicinska mikrobiologija
Sažetak (engleski)
Seronegative women are susceptible to primary rubella virus (RV) infection during pregnancy, which can cause fetal damage. Vaccination represents the main strategy in rubella prevention. The aim of this study was to analyze changes in the rubella seroprevalence and identify populations with a high susceptibility to RV. A cross-sectional study was performed on 6914 Caucasian fertile women who had Toxoplasma gondii, other viruses, Rubella, Cytomegalovirus, and the herpes simplex virus (TORCH) screening in two distinct periods-1452 at the Timișoara Municipal Hospital, Romania (Group 1: 2008-2010) and 5462 at the laboratory Bioclinica S.A., Timișoara, Romania (Group 2: 2015-2018). The RV seroprevalence decreased (Group 1 versus Group 2; 94.1% (92.7-95.2) versus 91.4% (90.6-92.1), OR = 0.76 (p = 0.0007)). According to the year of birth and eligibility to vaccination program, RV seroprevalence rates were 82.4% (76.8-86.8)/1997-2004, 85.4% (80.5-89.3)/1995-1996, 90.1% (89.0-91.1)/<1989, and 95.8% (94.7-96.6)/1989-1994. No significant difference in the RV seropositivity according to the place of residence was found. The overall RV susceptibility increased from 2008-2010 to 2015-2018. The highest susceptibility was found in women born between 1997-2004 eligible for measles-mumps-rubella (MMR) vaccine through the family practice system and the lowest in women born between 1989-1994 eligible for monovalent rubella vaccine conducted in schools.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaVaccines
Brojčani podacivol. 9, br. 2, 104
e-ISSN2076-393X
DOIhttps://doi.org/10.3390/vaccines9020104
URN:NBNurn:nbn:hr:105:126512
Datum objave publikacije2021-01-29
URL dokumentahttps://www.mdpi.com/2076-393X/9/2/104
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2021-07-02 09:46:04